Invega (paliperidone) is not primarily used as a first-line treatment for bipolar disorder. Invega is an antipsychotic medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics.
Bipolar disorder, on the other hand, is typically treated with mood stabilizers such as lithium, valproate, or certain anticonvulsant medications like lamotrigine or carbamazepine. Sometimes, atypical antipsychotic medications, including Invega, can be prescribed in combination with mood stabilizers to help manage specific symptoms like manic or mixed episodes in bipolar disorder.
The choice of treatment for bipolar disorder depends on various factors, including the type and severity of symptoms, a patient's medical history, and individual response to medications. If you or someone you know is experiencing symptoms of bipolar disorder, it is essential to seek help from a qualified mental health professional who can properly diagnose the condition and recommend appropriate treatment options.
Keep in mind that medical information may change over time, so I recommend consulting a healthcare professional or psychiatrist for the most up-to-date information regarding the treatment of bipolar disorder.